AZ’s potential Lupus treatment hits rocks in trial
AstraZeneca has revealed that a Phase III trial investigating its mAb treatment for Lupus came back with negative results.
AstraZeneca has revealed that a Phase III trial investigating its mAb treatment for Lupus came back with negative results.
The National Institute of Health (NIH) awarded $6.5m to a consortium of universities to create the Center for Reproducible Biomedical Modeling.